CYDY
Price:
$0.123
Market Cap:
$150.04M
CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as coronavirus disease (COVID-19). It is also conducting a Phase 1b/2 clinical trial with leronlimab in metastatic triple-negative breast cancer. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.[Read more]
Industry
Biotechnology
IPO Date
2006-12-13
Stock Exchange
PNK
Ticker
CYDY
According to CytoDyn Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -6.15. This represents a change of 152.10% compared to the average of -2.44 of the last 4 quarters.
The mean historical PE Ratio of CytoDyn Inc. over the last ten years is -3.50. The current -6.15 PE Ratio has changed 17.46% with respect to the historical average. Over the past ten years (40 quarters), CYDY's PE Ratio was at its highest in in the August 2024 quarter at 2.21. The PE Ratio was at its lowest in in the February 2021 quarter at -14.39.
Average
-3.50
Median
-2.88
Minimum
-8.82
Maximum
-0.80
Discovering the peaks and valleys of CytoDyn Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 365.92%
Maximum Annual PE Ratio = -0.80
Minimum Annual Increase = -88.46%
Minimum Annual PE Ratio = -8.82
Year | PE Ratio | Change |
---|---|---|
2024 | -3.01 | 9.79% |
2023 | -2.74 | 243.39% |
2022 | -0.80 | -88.46% |
2021 | -6.92 | -21.52% |
2020 | -8.82 | 365.92% |
2019 | -1.89 | 7.73% |
2018 | -1.76 | -45.33% |
2017 | -3.21 | -12.48% |
2016 | -3.67 | 67.28% |
2015 | -2.20 | -11.16% |
The current PE Ratio of CytoDyn Inc. (CYDY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.18
5-year avg
-4.46
10-year avg
-3.50
CytoDyn Inc.’s PE Ratio is greater than Intercept Pharmaceuticals, Inc. (-13.55), greater than Madrigal Pharmaceuticals, Inc. (-13.89), less than scPharmaceuticals Inc. (-2.59), greater than Akero Therapeutics, Inc. (-10.86), less than Aravive, Inc. (-0.04), less than Cardiff Oncology, Inc. (-4.10), less than Reviva Pharmaceuticals Holdings, Inc. (-1.05), less than eFFECTOR Therapeutics, Inc. (-0.00), less than PDS Biotechnology Corporation (-2.91), less than Navidea Biopharmaceuticals, Inc. (0.03),
Company | PE Ratio | Market cap |
---|---|---|
-13.55 | $794.69M | |
-13.89 | $7.23B | |
-2.59 | $201.62M | |
-10.86 | $2.23B | |
-0.04 | $2.95M | |
-4.10 | $174.10M | |
-1.05 | $33.39M | |
-0.00 | $1.88K | |
-2.91 | $118.93M | |
0.03 | $100.08K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoDyn Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoDyn Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CytoDyn Inc.'s PE Ratio?
How is the PE Ratio calculated for CytoDyn Inc. (CYDY)?
What is the highest PE Ratio for CytoDyn Inc. (CYDY)?
What is the 3-year average PE Ratio for CytoDyn Inc. (CYDY)?
What is the 5-year average PE Ratio for CytoDyn Inc. (CYDY)?
How does the current PE Ratio for CytoDyn Inc. (CYDY) compare to its historical average?